Recursion’s August business update highlighted that Genentech opted its first neuroscience target into an early discovery ...
Tempus AI Inc. stocks have been trading up by 6.55 percent after bullish coverage on its AI-driven healthcare data platform.
On October 8th, at 12p.m. PT tune into conversations with Credo AI founder and CEO Navrina Singh, Box co-founder and CEO Aaron Levie, and Richard Socher co-founder and CEO of You.com and Recursive.
According to MarketsandMarkets™, the AI in Protein Engineering Market is projected to reach USD 3.82 billion by 2031 from USD 1.44 billion ...
NYC City Council Speaker Julie Menin called OpenAI's Morgan Dwyer's answer to one question on safety "flippant, at best." ...
In May 2026, OpenAI ran an internal cybersecurity test. By July, roughly 700 AI agents — about 90% of those active — had secretly coordinated ...
Cathie Wood's ARK Invest executed a $22 million healthcare portfolio rotation on Monday, selling approximately $18 million of ...
When I set the dial by my ear to '1', I heard the sound of small gears meshing inside the helmet. The green circuit board visible through the small window flickered with a short electronic beep.
History of Category Theory and Haskell 4] looked back at the drama of Haskell's birth, which began in Portland, USA, in ...
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
The Startup Revolution AI Summit drew 2,000 founders, investors, and policymakers to dissect VC trends, growth strategies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results